Birner Dental Management Services (BDMS) 10-Q 14 Nov 16 2016 Q3 Quarterly report Financial data

Document and Entity Information

Document and Entity Information - shares	9 Months Ended
	Sep. 30, 2016	Nov. 03, 2016
Document and Entity Information [Abstract]
Entity Registrant Name	BIRNER DENTAL MANAGEMENT SERVICES INC
Entity Central Index Key	948,072
Current Fiscal Year End Date	--12-31
Entity Well-known Seasoned Issuer	No
Entity Voluntary Filers	No
Entity Current Reporting Status	Yes
Entity Filer Category	Smaller Reporting Company
Entity Common Stock, Shares Outstanding		1,860,261
Document Fiscal Year Focus	2,016
Document Fiscal Period Focus	Q3
Document Type	10-Q
Amendment Flag	false
Document Period End Date	Sep. 30, 2016

CONDENSED CONSOLIDATED BALANCE

CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) - USD ($)	Sep. 30, 2016	Dec. 31, 2015
CURRENT ASSETS:
Cash	$ 220,676	$ 258,801
Accounts receivable, net of allowance for doubtful accounts of approximately $390,000 and $390,000, respectively	3,350,154	3,043,655
Note receivable	34,195	34,195
Deferred tax asset	284,629	275,907
Income tax receivable	0	73,878
Prepaid expenses and other assets	779,071	575,770
Total current assets	4,668,725	4,262,206
PROPERTY AND EQUIPMENT, net	7,934,008	9,808,014
OTHER NONCURRENT ASSETS:
Intangible assets, net	6,932,225	7,565,648
Deferred charges and other assets	155,741	155,741
Note receivable	35,781	55,002
Total assets	19,726,480	21,846,611
CURRENT LIABILITIES:
Accounts payable	2,871,376	2,920,998
Accrued expenses	927,384	1,547,915
Accrued payroll and related expenses	2,239,065	2,330,398
Income taxes payable	10,328	0
Current maturities of long-term debt	2,000,000	1,500,000
Total current liabilities	8,048,153	8,299,311
LONG-TERM LIABILITIES:
Deferred tax liability, net	1,703,757	2,242,800
Long-term debt	7,938,934	8,707,578
Other long-term obligations	1,121,364	949,554
Total liabilities	18,812,208	20,199,243
SHAREHOLDERS' EQUITY:
Preferred Stock, no par value, 10,000,000 shares authorized; none outstanding	0	0
Common Stock, no par value, 20,000,000 shares authorized; 1,861,106 and 1,860,261 shares issued and outstanding, respectively	1,560,440	1,446,182
Retained earnings (accumulated deficit)	(646,168)	201,186
Total shareholders' equity	914,272	1,647,368
Total liabilities and shareholders' equity	$ 19,726,480	$ 21,846,611

CONDENSED CONSOLIDATED BALANCE3

CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) (Parenthetical) - USD ($)	Sep. 30, 2016	Dec. 31, 2015
CURRENT ASSETS:
Allowance for doubtful accounts	$ 390,000	$ 390,000
SHAREHOLDERS' EQUITY:
Preferred Stock, par value (in dollars per share)	$ 0	$ 0
Preferred Stock, authorized (in shares)	10,000,000	10,000,000
Preferred Stock, outstanding (in shares)	0	0
Common Stock, par value (in dollars per share)	$ 0	$ 0
Common Stock, authorized (in shares)	20,000,000	20,000,000
Common Stock, issued (in shares)	1,860,261	1,861,106
Common Stock, outstanding (in shares)	1,860,261	1,861,106

CONDENSED CONSOLIDATED STATEMEN

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) - USD ($)	3 Months Ended				9 Months Ended
	Sep. 30, 2016		Sep. 30, 2015		Sep. 30, 2016		Sep. 30, 2015
REVENUE:
Dental practice revenue	$ 13,988,133		$ 14,681,849		$ 44,009,444		$ 45,241,736
Capitation revenue	1,166,155		1,170,907		3,461,218		3,553,173
Total Revenue	15,154,288		15,852,756		47,470,662		48,794,909
DIRECT EXPENSES:
Clinical salaries and benefits	9,242,477		9,491,411		28,564,107		29,155,036
Dental supplies	729,299		762,736		2,187,229		2,261,936
Laboratory fees	869,014		851,678		2,648,658		2,516,851
Occupancy	1,591,841		1,514,141		4,712,445		4,426,666
Advertising and marketing	176,150		326,756		490,227		707,661
Depreciation and amortization	988,031		1,061,157		3,026,164		3,255,507
General and administrative	1,394,284		1,350,066		4,139,482		3,926,094
Total Direct Expenses	14,991,096		15,357,945		45,768,312		46,249,751
Contribution from dental offices	163,192		494,811		1,702,350		2,545,158
CORPORATE EXPENSES:
General and administrative	848,358	[1]	779,585	[1]	2,696,123	[2]	2,836,925	[2]
Depreciation and amortization	47,114		62,616		165,994		174,524
OPERATING LOSS	(732,280)		(347,390)		(1,159,767)		(466,291)
Interest expense, net	70,367		24,143		185,240		74,700
LOSS BEFORE INCOME TAXES	(802,647)		(371,533)		(1,345,007)		(540,991)
Income tax benefit	(286,131)		(144,897)		(497,653)		(210,986)
NET LOSS	$ (516,516)		$ (226,636)		$ (847,354)		$ (330,005)
Net loss per share of Common Stock - Basic (in dollars per share)	$ (0.28)		$ (0.12)		$ (0.46)		$ (0.18)
Net loss per share of Common Stock - Diluted (in dollars per share)	(0.28)		(0.12)		(0.46)		(0.18)
Cash dividends per share of Common Stock (in dollars per share)	$ 0		$ 0.22		$ 0		$ 0.66
Weighted average number of shares of Common Stock and dilutive securities:
Basic (in shares)	1,860,261		1,860,482		1,860,334		1,859,956
Diluted (in shares)	1,860,261		1,860,482		1,860,334		1,859,956
[1]	Corporate expense - general and administrative includes $42,075 and $32,309 of stock-based compensation expense pursuant to ASC Topic 718 for the quarters ended September 30, 2015 and 2016, respectively.
[2]	Corporate expense - general and administrative includes $169,338 and $123,118 of stock-based compensation expense pursuant to ASC Topic 718 for the nine months ended September 30, 2015 and 2016, respectively.

CONDENSED CONSOLIDATED STATEME5

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) (Parenthetical) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2016	Sep. 30, 2015	Sep. 30, 2016	Sep. 30, 2015
General and Administrative Expenses [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]
Stock based compensation expense	$ 32,309	$ 42,075	$ 123,118	$ 169,338

CONDENSED CONSOLIDATED STATEME6

CONDENSED CONSOLIDATED STATEMENT OF SHAREHOLDERS' EQUITY (UNAUDITED) - 9 months ended Sep. 30, 2016 - USD ($)	Common Stock [Member]	Retained Earnings (Accumulated Deficit) [Member]	Total
BALANCES at Dec. 31, 2015	$ 1,446,182	$ 201,186	$ 1,647,368
BALANCES (in shares) at Dec. 31, 2015	1,861,106		1,861,106
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Purchase and retirement of Common Stock	$ (8,860)	0	$ (8,860)
Purchase and retirement of Common Stock (in shares)	(845)
Stock-based compensation expense	$ 123,118	0	123,118
Net loss	0	(847,354)	(847,354)
BALANCES at Sep. 30, 2016	$ 1,560,440	$ (646,168)	$ 914,272
BALANCES (in shares) at Sep. 30, 2016	1,860,261		1,860,261

CONDENSED CONSOLIDATED STATEME7

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) - USD ($)	9 Months Ended
	Sep. 30, 2016	Sep. 30, 2015
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss	$ (847,354)	$ (330,005)
Adjustments to reconcile net loss to net cash provided by operating activities:
Depreciation and amortization	3,192,158	3,430,031
Stock-based compensation expense	123,118	169,338
Provision for doubtful accounts	635,522	568,820
Benefit from deferred income taxes	(547,765)	(573,601)
Gain on sale of assets	0	(3,948)
Changes in assets and liabilities
Accounts receivable	(942,021)	(739,788)
Prepaid expenses and other assets	(203,301)	(135,986)
Deferred charges and other assets	0	2,450
Accounts payable	(49,622)	(125,233)
Accrued expenses	(211,088)	(79,564)
Accrued payroll and related expenses	(91,333)	(92,214)
Income taxes payable (receivable)	84,206	233,646
Other long-term obligations	171,810	(64,831)
Net cash provided by operating activities	1,314,330	2,259,115
CASH FLOWS USED IN INVESTING ACTIVITIES:
Capital expenditures	(684,729)	(1,620,224)
Note receivable	19,221	20,788
Proceeds from sale of assets	0	5,000
Net cash used in investing activities	(665,508)	(1,594,436)
CASH FLOWS USED IN FINANCING ACTIVITIES:
Advances - line of credit	16,993,128	21,420,373
Repayments - line of credit	(16,261,772)	(20,856,031)
Repayments - reducing revolving loan	(1,000,000)	0
Proceeds from exercise of Common Stock options	0	7,671
Tax expense of Common Stock options exercised	0	(4,638)
Purchase and retirement of Common Stock	(8,860)	0
Common Stock cash dividends	(409,443)	(1,227,394)
Net cash used in financing activities	(686,947)	(660,019)
NET CHANGE IN CASH	(38,125)	4,660
CASH, beginning of period	258,801	310,229
CASH, end of period	220,676	314,889
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION:
Cash paid for interest	199,982	109,890
Cash paid for income taxes	50,906	138,535
Cash received for income taxes	85,000	4,929
NON-CASH ITEMS:
Repayments - line of credit with Compass Bank	$ 10,617,598	$ 0

UNAUDITED CONDENSED CONSOLIDATE

UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS	9 Months Ended
	Sep. 30, 2016
UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS [Abstract]
UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS	(1) UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS The condensed consolidated financial statements included herein are unaudited and have been prepared by Birner Dental Management Services, Inc. (the “Company”) pursuant to the rules and regulations of the Securities and Exchange Commission (the “SEC”). Certain information and footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States (“GAAP”) have been condensed or omitted pursuant to such rules and regulations, although the Company believes that the disclosures included herein are adequate to make the information presented not misleading. A description of the Company’s accounting policies and other financial information is included in the audited consolidated financial statements as filed with the SEC in the Company’s Annual Report on Form 10-K for the year ended December 31, 2015. In the opinion of management, the accompanying unaudited condensed consolidated financial statements contain all adjustments necessary to present fairly the financial position of the Company as of September 30, 2016 and the results of operations and cash flows for the periods presented. All such adjustments are of a normal recurring nature. The results of operations for the quarter and nine months ended September 30, 2016 are not necessarily indicative of the results that may be achieved for a full fiscal year and cannot be used to indicate financial performance for the entire year.

SIGNIFICANT ACCOUNTING POLICIES

SIGNIFICANT ACCOUNTING POLICIES	9 Months Ended
	Sep. 30, 2016
SIGNIFICANT ACCOUNTING POLICIES [Abstract]
SIGNIFICANT ACCOUNTING POLICIES	(2) SIGNIFICANT ACCOUNTING POLICIES Basis of Presentation/Basis of Consolidation The accompanying condensed consolidated financial statements have been prepared on the accrual basis of accounting. These financial statements present the financial position and results of operations of the Company and the dental offices (“Offices”), which are under the control of the Company. The Offices are organized as professional corporations (“P.C.s”) and the Company provides business services to the Offices under long-term management agreements (the “Management Agreements”). All intercompany accounts and transactions have been eliminated in the consolidation. The Company treats Offices as consolidated subsidiaries where it has a long-term and unilateral controlling financial interest over the assets and operations of the Offices. The Company maintains control of substantially all of its Offices via the Management Agreements. The Company is a business service organization and does not engage in the practice of dentistry or the provision of dental hygiene services. These services are provided by licensed professionals. Certain key features of these arrangements either enable the Company at any time and in its sole discretion to cause a change in the shareholder of the P.C. (i.e., ''nominee shareholder'') or allow the Company to vote the shares of stock held by the owner of the P.C. and to elect a majority of the board of directors of the P.C. The accompanying condensed consolidated statements of operations reflect revenue, which is the amount billed to patients less contractual adjustments. Direct expenses consist of all the expenses incurred in operating the Offices and paid by the Company. Under the Management Agreements, the Company assumes responsibility for the management of most aspects of the Offices' business (the Company does not engage in the practice of dentistry or the provision of dental hygiene services), including personnel recruitment and training; comprehensive administrative, business and marketing support and advice; and facilities, equipment, and support personnel as required to operate the practices. The Company prepares its consolidated financial statements in accordance with Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) 810, which provides for consolidation of variable interest entities (“VIEs”) of which the Company is the primary beneficiary. The Company has concluded that the P.C.s meet the definition of VIEs as defined by this standard and that the Company is the primary beneficiary of these VIEs. This conclusion was reached because the Company has the power to direct significant activities of the VIEs and the Company is obligated to absorb losses of and/or provide rights to receive benefits from the VIEs. Revenue Revenue is generally recognized when services are provided and is reported at estimated net realizable amounts due from insurance companies, preferred provider and health maintenance organizations (i.e., third-party payors) and patients for services rendered, net of contractual and other adjustments. Dental services are billed and collected by the Company in the name of the Offices. Revenue under certain third-party payor agreements is subject to audit and retroactive adjustments. To the Company’s knowledge, there are no material claims, disputes or other unsettled matters that exist concerning third-party reimbursements as of September 30, 2016. Most of the Company’s patients are insured under third-party payor agreements. The Company’s billing system generates contractual adjustments for each patient encounter based on fee schedules for the patient’s insurance plan. The services provided are attached to the patient’s fee schedule based on the insurance the patient has at the time the service is provided. Therefore, the revenue that is recorded by the billing system is based on insurance contractual amounts. Additionally, each patient at the time of service signs a form agreeing that the patient is ultimately responsible for the contracted fee if the insurance company does not pay the fee for any reason. Note Receivable A note receivable was created as part of a dental Office acquisition, of which approximately $70,000 in principal amount was outstanding at September 30, 2016. The note has equal monthly principal and interest amortization payments and a maturity date of October 31, 2018. The note bears interest at 6%, which is accrued monthly. If the note is uncollectible, an allowance for doubtful accounts will be created. There was no allowance for doubtful accounts for the note as of September 30, 2016 or December 31, 2015. Intangible Assets The Company's dental practice acquisitions involve the purchase of tangible and intangible assets and the assumption of certain liabilities of the acquired dental Offices. As part of the purchase price allocation, the Company allocates the purchase price to the The Management Agreements cannot be terminated by a P.C. without cause, consisting primarily of bankruptcy or material default by the Company. If facts and circumstances indicate that the carrying value of long-lived and intangible assets may be impaired, the Company will perform an evaluation of recoverability. If an evaluation is required, the estimated future undiscounted cash flows associated with the asset will be compared to the asset’s carrying amount to determine if a write-down to market value or discounted cash flow value is required. There were no impairment write-downs associated with the Company’s long-lived and intangible assets during the quarters ended September 30, 2016 and 2015. Stock-Based Compensation Expense The Company recognizes compensation expense on a straight line basis over the requisite service period of the award. Total stock-based compensation expense included in the Company’s condensed consolidated statements of operations for the quarters ended September 30, 2016 and 2015 was approximately $32,000 and $42,000, respectively, related to stock options. Total stock-based compensation expense included in the Company’s condensed consolidated statements of operations for the nine months ended September 30, 2016 and 2015 was approximately $123,000 and $169,000, respectively, related to stock options. Total stock-based compensation expense was recorded as a component of corporate general and administrative expense. The Black-Scholes option-pricing model was used to estimate the option fair values. The option-pricing model requires a number of assumptions, of which the most significant are expected stock price volatility, the expected pre-vesting forfeiture rate, expected dividend rate and the expected option term (the amount of time from the grant date until the options are exercised or expire). Expected volatility was calculated based upon actual historical stock price movements over the most recent periods ended September 30, 2016 equal to the expected option term. Expected pre-vesting forfeitures were estimated based on historical pre-vesting forfeitures over the most recent periods ended September 30, 2016 for the expected option term. Recent Accounting Pronouncements In May 2014, the FASB issued Accounting Standards Update (“ASU”) No. 2014-09, Revenue from Contracts with Customers (Topic 606). In August 2014, the FASB issued ASU No. 2014-15, Presentation of Financial Statements-Going Concern (Subtopic 205-40): Disclosure of Uncertainties about an Entity’s Ability to Continue as a Going Concern. In April 2015, the FASB issued ASU No. 2015-03, Interest – Imputation of Interest (Subtopic 835-30): Simplifying the Presentation of Debt Issuance Costs. In November 2015, the FASB issued ASU No. 2015-17, Income Taxes (Topic 740): Balance Sheet Classification of Deferred Taxes. In February 2016, the FASB issued ASU No. 2016-02, Leases (Topic 842). In March 2016, the FASB issued ASU No. 2016-09, Improvements to Employee Share-Based Payment Accounting. In August 2016, the FASB issued ASU No. 2016-15, Statement of Cash Flows (Topic 230) Classification of Certain Cash Receipts and Cash Payments.

LOSS PER SHARE

LOSS PER SHARE	9 Months Ended
	Sep. 30, 2016
LOSS PER SHARE [Abstract]
LOSS PER SHARE	(3) LOSS PER SHARE The Company calculates earnings (loss) per share (“EPS”) in accordance with ASC Topic 260. Quarters Ended September 30, 2015 2016 Net Loss Shares Per Share Amount Net Loss Shares Per Share Amount Basic EPS $ (226,636 ) 1,860,482 $ (0.12 ) $ (516,516 ) 1,860,261 $ (0.28 ) Effect of Dilutive Stock Options - - - - - - Diluted EPS $ (226,636 ) 1,860,482 $ (0.12 ) $ (516,516 ) 1,860,261 $ (0.28 ) For the quarters ended September 30, 2016 and 2015, options to purchase 509,000 and 455,666 shares, respectively, of the Company’s common stock (“Common Stock”) were not included in the computation of diluted EPS because their effect was anti-dilutive. Nine Months Ended September 30, 2015 2016 Net Loss Shares Per Share Amount Net Loss Shares Per Share Amount Basic EPS $ (330,005 ) 1,859,956 $ (0.18 ) $ (847,354 ) 1,860,334 $ (0.46 ) Effect of Dilutive Stock Options - - - - - - Diluted EPS $ (330,005 ) 1,859,956 $ (0.18 ) $ (847,354 ) 1,860,334 $ (0.46 ) For the nine months ended September 30, 2016 and 2015, options to purchase 509,000 and 455,666 shares, respectively, of Common Stock were not included in the computation of diluted EPS because their effect was anti-dilutive.

STOCK-BASED COMPENSATION PLANS

STOCK-BASED COMPENSATION PLANS	9 Months Ended
	Sep. 30, 2016
STOCK-BASED COMPENSATION PLANS [Abstract]
STOCK-BASED COMPENSATION PLANS	(4) STOCK-BASED COMPENSATION PLANS The Company’s 2005 Equity Incentive Plan, as amended (“2005 Plan”), terminated in March 2015. The 2005 Plan provided for the grant of incentive stock options, restricted stock, restricted stock units and stock grants to eligible employees (including officers and employee-directors) and non-statutory stock options to eligible employees, directors and consultants. As of September 30, 2016, there were 324,589 vested options and 103,411 unvested options granted under the 2005 Plan that remained outstanding in accordance with their terms and there were no shares available for issuance under the 2005 Plan due to its termination. The Company’s shareholders approved the 2015 Equity Incentive Plan (“2015 Plan”) in June 2015. The 2015 Plan replaces the 2005 Plan. The maximum number of shares of Common Stock that may be delivered to participants and their beneficiaries under the 2015 Plan is 200,000. The 2015 Plan provides for the grant of incentive stock options, stock appreciation right awards, restricted stock awards, stock unit awards and other stock-based awards to eligible recipients. The objectives of the 2015 Plan are to attract and retain the best possible candidates for positions of responsibility and provide for additional performance incentives by providing eligible employees with the opportunity to acquire equity in the Company. The 2015 Plan is administered by a committee of two or more outside directors from the Company’s Board of Directors (the “Committee”). The Committee determines the eligible individuals to whom awards under the 2015 Plan may be granted, as well as the time or times at which awards will be granted, the number of shares subject to awards to be granted to any eligible individual, the term of the award, vesting terms and conditions and any other terms and conditions of the grant in addition to those contained in the 2015 Plan. Each grant under the 2015 Plan will be confirmed by and subject to the terms of an award agreement. The Company uses the Black-Scholes option-pricing model to estimate the fair value of each option granted with the following weighted average assumptions: Quarters Ended September 30, Nine Months Ended September 30, Valuation Assumptions 2015 2016 (5) 2015 2016 Expected life (1) 3.25 - 3.25 3.25 Risk-free interest rate (2) 1.00 % - 1.00 % 1.21 % Expected volatility (3) 35 % - 35 % 39 % Expected dividend yield 6.93 % - 6.93 % 7.81 % Expected forfeiture (4) 27.00 % - 27.00 % 27.00 % (1) The expected life, in years, of stock options is estimated based on historical experience. (2) The risk-free interest rate is based on U.S. Treasury bills whose term is consistent with the expected life of the stock options. (3) The expected volatility is estimated based on historical and current stock price data for the Company. (4) Forfeitures are estimated based on historical experience. (5) The Company did not issue any options during the quarter ended September 30, 2016. A summary of option activity as of September 30, 2016, and changes during the nine months then ended, is presented below: Number of Options Weighted- Average Exercise Price Range of Exercise Prices Weighted- Average Remaining Contractual Term (years) Aggregate Intrinsic Value (thousands) Outstanding at January 1, 2016 455,666 $ 16.82 $ 12.55 - $19.75 4.2 $ - Granted 95,000 $ 10.11 $ 10.04 - $11.11 Cancelled (41,666 ) $ 12.69 $ 10.04 - $16.50 Outstanding at September 30, 2016 509,000 $ 15.91 $ 10.04 - $19.75 3.7 $ 968 Exercisable at September 30, 2016 324,589 $ 17.76 $ 12.55 - $19.75 2.5 $ 160,764 No options were granted or exercised during the quarter ended September 30, 2016. The weighted average grant date fair value of options granted during the nine months ended September 30, 2015 was $1.81 per share. Net cash proceeds from the exercise of stock options during the nine months ended September 30, 2015 were approximately $8,000. The associated income tax effect from stock options exercised during the nine months ended September 30, 2015 was approximately $(5,000). As of the date of exercise, the total intrinsic value of options exercised during the nine months ended September 30, 2015 was approximately $11,000. As of September 30, 2016, there was approximately $182,000 of total unrecognized compensation expense related to non-vested stock options, which is expected to be recognized over a weighted average period of 2.23 years.

DIVIDENDS

DIVIDENDS	9 Months Ended
	Sep. 30, 2016
DIVIDENDS [Abstract]
DIVIDENDS	(5) DIVIDENDS The Company has declared and paid the following quarterly cash dividends. Date Dividend Paid Quarterly Dividend Paid per Share January 2014; April 2014; July 2014; October 2014 $ 0.22 January 2015; April 2015; July 2015; October 2015 January 2016 The payment of dividends in the future is subject to the discretion of the Company’s Board of Directors, and various factors may prevent the Company from paying dividends or require the Company to reduce the dividends. Such factors include the Company’s financial position, capital requirements and liquidity, the existence of a stock repurchase program, credit agreement restrictions, state corporate law restrictions, results of operations and such other factors that the Company’s Board of Directors may consider relevant. On March 29, 2016, the Company entered into a new Loan and Security Agreement with Guaranty Bank and Trust Company, which was amended on July 29, 2016 and November 14, 2016 (as amended, the “Credit Facility”). Through the remainder of 2016, dividends are prohibited under the Credit Facility. Beginning in 2017, dividends are permitted so long as the pro forma fixed charge coverage ratio is greater than 1.20 to 1.00 after giving effect to the dividend.

LINE OF CREDIT

LINE OF CREDIT	9 Months Ended
	Sep. 30, 2016
LINE OF CREDIT [Abstract]
LINE OF CREDIT	(6) LINE OF CREDIT The Credit Facility consists of a $2.0 million revolving line of credit and a $10.0 million reducing revolving loan. The revolving line of credit matures on March 31, 2018. The reducing revolving loan matures on March 31, 2021 and requires mandatory reductions of $500,000 per calendar quarter beginning July 1, 2016. The reducing revolving loan allows the Company to drawdown, repay and re-draw loans advanced to it within the available balance. Interest varies between LIBOR plus 2.90% and LIBOR plus 2.25% depending on the Company’s funded debt-to-EBITDA ratio. As of September 30, 2016, the revolving line of credit rate was 3.42% and the reducing revolving loan rate was 3.42%. There is no commitment fee or origination fee on the Credit Facility. At September 30, 2016, the Company had approximately $1.0 million of borrowings outstanding under the revolving line of credit and approximately $1.0 million available for borrowing under the revolving line of credit. At September 30, 2016, the Company had approximately $9.0 million of borrowings outstanding under the reducing revolving loan. The Credit Facility is collateralized by substantially all of the assets of the Company. The Credit Facility requires the Company to comply with certain affirmative and negative covenants, including maintaining (i) a funded debt-to-EBITDA ratio of no more than 3.15 to 1.00 for the twelve months ending December 31, 2016 and 3.00 to 1.00 for the twelve months ending March 31, 2017, declining to 2.10 to 1.00 for the twelve months ending June 30, 2017, 2.00 to 1.00 for the twelve months ending September 30, 2017 and 1.90 to 1.00 thereafter, (ii) net worth of at least $1.0 million (increased by 25% of any net income after taxes of the Company in 2016 and thereafter), and (iii) a fixed charge coverage ratio of not less than 1.35 to 1.00. In addition, the Company must generate at least $650,000 of EBITDA in the quarter ending December 31, 2016 and at least $1,830,000 of EBITDA in the six months ending March 31, 2017. At September 30, 2016, the Company was not in compliance with the Credit Facility covenant that required a funded debt-to-EBITDA ratio of 2.40 to 1.00 for the annualized period ending September 30, 2016. The Company obtained a waiver of compliance with such covenant in connection with the November 2016 amendment to the Credit Facility, which also relaxed the funded debt-to-EBITDA ratio covenant for the twelve months ending December 31, 2016 and March 31, 2017 and added the EBITDA covenant described above. On March 30, 2016, the Company terminated its credit facility with Compass Bank. The Company repaid the outstanding $10.6 million principal amount plus accrued interest under the credit agreement with Compass Bank with borrowings under the new Credit Facility.

DISCLOSURES ABOUT FAIR VALUE OF

DISCLOSURES ABOUT FAIR VALUE OF FINANCIAL INSTRUMENTS	9 Months Ended
	Sep. 30, 2016
DISCLOSURES ABOUT FAIR VALUE OF FINANCIAL INSTRUMENTS [Abstract]
DISCLOSURES ABOUT FAIR VALUE OF FINANCIAL INSTRUMENTS	(7) DISCLOSURES ABOUT FAIR VALUE OF FINANCIAL INSTRUMENTS ASC Topic 825, ''Disclosures About Fair Value of Financial Instruments,'' requires disclosure about the fair value of financial instruments. Carrying amounts for all financial instruments included in current assets and current liabilities approximate estimated fair values due to the short maturity of those instruments. The fair values of the Company's long-term debt are based on similar rates currently available to the Company. The Company believes the book value approximates fair value for the notes receivable. The Company follows ASC Topic 820, “Fair Value Measurements and Disclosures,” which defines fair value, establishes a framework for using fair value to measure assets and liabilities, and expands disclosures about fair value measurements. The statement establishes a hierarchy for inputs used in measuring fair value that maximizes the use of observable inputs and minimizes the use of unobservable inputs by requiring that the most observable inputs be used when available. Observable inputs are inputs that market participants would use in pricing the asset or liability developed based on market data obtained from sources independent of the Company. Unobservable inputs are inputs that reflect the Company’s assumptions of what market participants would use in pricing the asset or liability developed based on the best information available in the circumstances. The hierarchy is broken down into three levels based on the reliability of the inputs as follows: Level Quoted prices are available in active markets for identical assets or liabilities. Level 2: Quoted prices in active markets for similar assets and liabilities that are observable for the asset or liability; or Level 3: Unobservable pricing inputs that are generally less observable from objective sources, such as discounted cash flow models or valuations. The following table represents the Company’s financial assets and liabilities that were accounted for at fair value on a recurring basis as of December 31, 2015 and September 30, 2016 by level within the fair value hierarchy: December 31, 2015 September 30, 2016 Level 1 Level 2 Level 3 Level 1 Level 2 Level 3 Contingent Liabilities Balance $ - - $ 321,000 $ - - $ 321,000 Contingent Liabilities As part of an Office acquisition completed in 2009, the Company recorded contingent liabilities to recognize an estimated amount to be paid as part of the acquisition agreement. These contingent liabilities are recorded at estimated fair values as of the date of acquisition, are payable beginning after four years from the acquisition date and are calculated at a multiple of the then trailing twelve-months operating cash flows. The Company remeasures the contingent liability to fair value each reporting date until the contingency is resolved. Any changes to the fair value are recognized into the income statement when determined. As of September 30, 2016, approximately $321,000 of contingent liabilities were recorded on the consolidated balance sheets in other long-term obligations.

SIGNIFICANT ACCOUNTING POLICI15

SIGNIFICANT ACCOUNTING POLICIES (Policies)	9 Months Ended
	Sep. 30, 2016
SIGNIFICANT ACCOUNTING POLICIES [Abstract]
Basis of Presentation/Basis of Consolidation	Basis of Presentation/Basis of Consolidation The accompanying condensed consolidated financial statements have been prepared on the accrual basis of accounting. These financial statements present the financial position and results of operations of the Company and the dental offices (“Offices”), which are under the control of the Company. The Offices are organized as professional corporations (“P.C.s”) and the Company provides business services to the Offices under long-term management agreements (the “Management Agreements”). All intercompany accounts and transactions have been eliminated in the consolidation. The Company treats Offices as consolidated subsidiaries where it has a long-term and unilateral controlling financial interest over the assets and operations of the Offices. The Company maintains control of substantially all of its Offices via the Management Agreements. The Company is a business service organization and does not engage in the practice of dentistry or the provision of dental hygiene services. These services are provided by licensed professionals. Certain key features of these arrangements either enable the Company at any time and in its sole discretion to cause a change in the shareholder of the P.C. (i.e., ''nominee shareholder'') or allow the Company to vote the shares of stock held by the owner of the P.C. and to elect a majority of the board of directors of the P.C. The accompanying condensed consolidated statements of operations reflect revenue, which is the amount billed to patients less contractual adjustments. Direct expenses consist of all the expenses incurred in operating the Offices and paid by the Company. Under the Management Agreements, the Company assumes responsibility for the management of most aspects of the Offices' business (the Company does not engage in the practice of dentistry or the provision of dental hygiene services), including personnel recruitment and training; comprehensive administrative, business and marketing support and advice; and facilities, equipment, and support personnel as required to operate the practices. The Company prepares its consolidated financial statements in accordance with Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) 810, which provides for consolidation of variable interest entities (“VIEs”) of which the Company is the primary beneficiary. The Company has concluded that the P.C.s meet the definition of VIEs as defined by this standard and that the Company is the primary beneficiary of these VIEs. This conclusion was reached because the Company has the power to direct significant activities of the VIEs and the Company is obligated to absorb losses of and/or provide rights to receive benefits from the VIEs.
Revenue	Revenue Revenue is generally recognized when services are provided and is reported at estimated net realizable amounts due from insurance companies, preferred provider and health maintenance organizations (i.e., third-party payors) and patients for services rendered, net of contractual and other adjustments. Dental services are billed and collected by the Company in the name of the Offices. Revenue under certain third-party payor agreements is subject to audit and retroactive adjustments. To the Company’s knowledge, there are no material claims, disputes or other unsettled matters that exist concerning third-party reimbursements as of September 30, 2016. Most of the Company’s patients are insured under third-party payor agreements. The Company’s billing system generates contractual adjustments for each patient encounter based on fee schedules for the patient’s insurance plan. The services provided are attached to the patient’s fee schedule based on the insurance the patient has at the time the service is provided. Therefore, the revenue that is recorded by the billing system is based on insurance contractual amounts. Additionally, each patient at the time of service signs a form agreeing that the patient is ultimately responsible for the contracted fee if the insurance company does not pay the fee for any reason.
Note Receivable	Note Receivable A note receivable was created as part of a dental Office acquisition, of which approximately $70,000 in principal amount was outstanding at September 30, 2016. The note has equal monthly principal and interest amortization payments and a maturity date of October 31, 2018. The note bears interest at 6%, which is accrued monthly. If the note is uncollectible, an allowance for doubtful accounts will be created. There was no allowance for doubtful accounts for the note as of September 30, 2016 or December 31, 2015.
Intangible Assets	Intangible Assets The Company's dental practice acquisitions involve the purchase of tangible and intangible assets and the assumption of certain liabilities of the acquired dental Offices. As part of the purchase price allocation, the Company allocates the purchase price to the The Management Agreements cannot be terminated by a P.C. without cause, consisting primarily of bankruptcy or material default by the Company. If facts and circumstances indicate that the carrying value of long-lived and intangible assets may be impaired, the Company will perform an evaluation of recoverability. If an evaluation is required, the estimated future undiscounted cash flows associated with the asset will be compared to the asset’s carrying amount to determine if a write-down to market value or discounted cash flow value is required. There were no impairment write-downs associated with the Company’s long-lived and intangible assets during the quarters ended September 30, 2016 and 2015.
Stock-Based Compensation Expense	Stock-Based Compensation Expense The Company recognizes compensation expense on a straight line basis over the requisite service period of the award. Total stock-based compensation expense included in the Company’s condensed consolidated statements of operations for the quarters ended September 30, 2016 and 2015 was approximately $32,000 and $42,000, respectively, related to stock options. Total stock-based compensation expense included in the Company’s condensed consolidated statements of operations for the nine months ended September 30, 2016 and 2015 was approximately $123,000 and $169,000, respectively, related to stock options. Total stock-based compensation expense was recorded as a component of corporate general and administrative expense. The Black-Scholes option-pricing model was used to estimate the option fair values. The option-pricing model requires a number of assumptions, of which the most significant are expected stock price volatility, the expected pre-vesting forfeiture rate, expected dividend rate and the expected option term (the amount of time from the grant date until the options are exercised or expire). Expected volatility was calculated based upon actual historical stock price movements over the most recent periods ended September 30, 2016 equal to the expected option term. Expected pre-vesting forfeitures were estimated based on historical pre-vesting forfeitures over the most recent periods ended September 30, 2016 for the expected option term.
Recent Accounting Pronouncements	Recent Accounting Pronouncements In May 2014, the FASB issued Accounting Standards Update (“ASU”) No. 2014-09, Revenue from Contracts with Customers (Topic 606). In August 2014, the FASB issued ASU No. 2014-15, Presentation of Financial Statements-Going Concern (Subtopic 205-40): Disclosure of Uncertainties about an Entity’s Ability to Continue as a Going Concern. In April 2015, the FASB issued ASU No. 2015-03, Interest – Imputation of Interest (Subtopic 835-30): Simplifying the Presentation of Debt Issuance Costs. In November 2015, the FASB issued ASU No. 2015-17, Income Taxes (Topic 740): Balance Sheet Classification of Deferred Taxes. In February 2016, the FASB issued ASU No. 2016-02, Leases (Topic 842). In March 2016, the FASB issued ASU No. 2016-09, Improvements to Employee Share-Based Payment Accounting. In August 2016, the FASB issued ASU No. 2016-15, Statement of Cash Flows (Topic 230) Classification of Certain Cash Receipts and Cash Payments.

LOSS PER SHARE (Tables)

LOSS PER SHARE (Tables)	9 Months Ended
	Sep. 30, 2016
LOSS PER SHARE [Abstract]
Earnings (loss) per share calculation	The Company calculates earnings (loss) per share (“EPS”) in accordance with ASC Topic 260. Quarters Ended September 30, 2015 2016 Net Loss Shares Per Share Amount Net Loss Shares Per Share Amount Basic EPS $ (226,636 ) 1,860,482 $ (0.12 ) $ (516,516 ) 1,860,261 $ (0.28 ) Effect of Dilutive Stock Options - - - - - - Diluted EPS $ (226,636 ) 1,860,482 $ (0.12 ) $ (516,516 ) 1,860,261 $ (0.28 ) For the quarters ended September 30, 2016 and 2015, options to purchase 509,000 and 455,666 shares, respectively, of the Company’s common stock (“Common Stock”) were not included in the computation of diluted EPS because their effect was anti-dilutive. Nine Months Ended September 30, 2015 2016 Net Loss Shares Per Share Amount Net Loss Shares Per Share Amount Basic EPS $ (330,005 ) 1,859,956 $ (0.18 ) $ (847,354 ) 1,860,334 $ (0.46 ) Effect of Dilutive Stock Options - - - - - - Diluted EPS $ (330,005 ) 1,859,956 $ (0.18 ) $ (847,354 ) 1,860,334 $ (0.46 )

STOCK-BASED COMPENSATION PLANS

STOCK-BASED COMPENSATION PLANS (Tables)	9 Months Ended
	Sep. 30, 2016
STOCK-BASED COMPENSATION PLANS [Abstract]
Schedule of estimated fair value option granted	The Company uses the Black-Scholes option-pricing model to estimate the fair value of each option granted with the following weighted average assumptions: Quarters Ended September 30, Nine Months Ended September 30, Valuation Assumptions 2015 2016 (5) 2015 2016 Expected life (1) 3.25 - 3.25 3.25 Risk-free interest rate (2) 1.00 % - 1.00 % 1.21 % Expected volatility (3) 35 % - 35 % 39 % Expected dividend yield 6.93 % - 6.93 % 7.81 % Expected forfeiture (4) 27.00 % - 27.00 % 27.00 % (1) The expected life, in years, of stock options is estimated based on historical experience. (2) The risk-free interest rate is based on U.S. Treasury bills whose term is consistent with the expected life of the stock options. (3) The expected volatility is estimated based on historical and current stock price data for the Company. (4) Forfeitures are estimated based on historical experience. (5) The Company did not issue any options during the quarter ended September 30, 2016.
Summary of option activity	A summary of option activity as of September 30, 2016, and changes during the nine months then ended, is presented below: Number of Options Weighted- Average Exercise Price Range of Exercise Prices Weighted- Average Remaining Contractual Term (years) Aggregate Intrinsic Value (thousands) Outstanding at January 1, 2016 455,666 $ 16.82 $ 12.55 - $19.75 4.2 $ - Granted 95,000 $ 10.11 $ 10.04 - $11.11 Cancelled (41,666 ) $ 12.69 $ 10.04 - $16.50 Outstanding at September 30, 2016 509,000 $ 15.91 $ 10.04 - $19.75 3.7 $ 968 Exercisable at September 30, 2016 324,589 $ 17.76 $ 12.55 - $19.75 2.5 $ 160,764

DIVIDENDS (Tables)

DIVIDENDS (Tables)	9 Months Ended
	Sep. 30, 2016
DIVIDENDS [Abstract]
Dividends payable	The Company has declared and paid the following quarterly cash dividends. Date Dividend Paid Quarterly Dividend Paid per Share January 2014; April 2014; July 2014; October 2014 $ 0.22 January 2015; April 2015; July 2015; October 2015 January 2016

DISCLOSURES ABOUT FAIR VALUE 19

DISCLOSURES ABOUT FAIR VALUE OF FINANCIAL INSTRUMENTS (Tables)	9 Months Ended
	Sep. 30, 2016
DISCLOSURES ABOUT FAIR VALUE OF FINANCIAL INSTRUMENTS [Abstract]
Fair value, assets and liabilities measured on recurring basis	The following table represents the Company’s financial assets and liabilities that were accounted for at fair value on a recurring basis as of December 31, 2015 and September 30, 2016 by level within the fair value hierarchy: December 31, 2015 September 30, 2016 Level 1 Level 2 Level 3 Level 1 Level 2 Level 3 Contingent Liabilities Balance $ - - $ 321,000 $ - - $ 321,000

SIGNIFICANT ACCOUNTING POLICI20

SIGNIFICANT ACCOUNTING POLICIES (Details) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2016	Sep. 30, 2015	Sep. 30, 2016	Sep. 30, 2015	Dec. 31, 2015
Note Receivable [Abstract]
Outstanding principal amount of note receivables	$ 70,000		$ 70,000
Maturity date			Oct. 31, 2018
Interest rate on notes receivable			6.00%
Allowance for doubtful accounts	0		$ 0		$ 0
Intangible Assets [Abstract]
Life of the management agreement			40 years
Amortization period for contract			25 years
Amortization expense	211,000	$ 211,000	$ 633,000	$ 634,000
Impairment of Long-Lived and Intangible Assets [Abstract]
Impairment of long-lived and intangible assets	0	0	0	0
Stock Options [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock based compensation expense	$ 32,000	$ 42,000	$ 123,000	$ 169,000

LOSS PER SHARE (Details)

LOSS PER SHARE (Details) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2016	Sep. 30, 2015	Sep. 30, 2016	Sep. 30, 2015
Net loss, diluted [Abstract]
Net loss, basic EPS	$ (516,516)	$ (226,636)	$ (847,354)	$ (330,005)
Effect of dilutive stock options	0	0	0	0
Net loss, diluted EPS	$ (516,516)	$ (226,636)	$ (847,354)	$ (330,005)
Weighted average number of shares outstanding reconciliation [Abstract]
Weighted average number of shares, basic EPS (in shares)	1,860,261	1,860,482	1,860,334	1,859,956
Effect of dilutive stock options, shares (in shares)	0	0	0	0
Weighted average number of shares outstanding, diluted EPS (in shares)	1,860,261	1,860,482	1,860,334	1,859,956
Earnings per share, basic and diluted [Abstract]
Earnings per share, basic EPS (in dollars per share)	$ (0.28)	$ (0.12)	$ (0.46)	$ (0.18)
Effect of dilutive stock option (in dollars per share)	0	0	0	0
Per share amount - diluted EPS (in dollars per share)	$ (0.28)	$ (0.12)	$ (0.46)	$ (0.18)
Antidilutive securities (in shares)	509,000	455,666	509,000	455,666

STOCK-BASED COMPENSATION PLAN22

STOCK-BASED COMPENSATION PLANS (Details) - Stock Options [Member]		3 Months Ended			9 Months Ended		12 Months Ended
		Sep. 30, 2016USD ($)Administrator$ / sharesshares		Sep. 30, 2015	Sep. 30, 2016USD ($)Administrator$ / sharesshares	Sep. 30, 2015USD ($)$ / shares	Dec. 31, 2015USD ($)$ / sharesshares
Fair value assumptions [Abstract]
Expected life	[2]	0 years	[1]	3 years 3 months	3 years 3 months	3 years 3 months
Risk-free interest rate	[3]	0.00%	[1]	1.00%	1.21%	1.00%
Expected volatility	[4]	0.00%	[1]	35.00%	39.00%	35.00%
Expected dividend yield		0.00%	[1]	6.93%	7.81%	6.93%
Expected forfeiture	[5]	0.00%	[1]	27.00%	27.00%	27.00%
Options outstanding [Roll Forward]
Outstanding, beginning balance (in shares) | shares					455,666
Granted (in shares) | shares		0			95,000
Exercised (in shares) | shares		0
Cancelled (in shares) | shares					(41,666)
Outstanding, ending balance (in shares) | shares		509,000			509,000		455,666
Exercisable (in shares) | shares		324,589			324,589
Options weighted average exercise price [Roll Forward]
Outstanding, beginning balance (in dollars per share)					$ 16.82
Granted (in dollars per share)					10.11
Cancelled (in dollars per share)					12.69
Outstanding, ending balance (in dollars per share)		$ 15.91			15.91		$ 16.82
Exercisable (in dollars per share)		$ 17.76			$ 17.76
Options, additional disclosures [Abstract]
Outstanding, weighted average remaining contractual term					3 years 8 months 12 days		4 years 2 months 12 days
Outstanding, aggregate intrinsic value | $		$ 968,000			$ 968,000		$ 0
Exercisable, weighted average remaining contractual term					2 years 6 months
Exercisable, aggregate intrinsic value | $		160,764,000			$ 160,764,000
Weighted average grant date fair value of options (in dollars per share)						$ 1.81
Net cash proceeds from the exercise of stock options | $						$ 8,000
Income tax effect | $						(5,000)
Intrinsic value | $						$ 11,000
Total unrecognized compensation expense | $		$ 182,000			$ 182,000
Weighted average period for recognition					2 years 2 months 23 days
Minimum [Member]
Range of Exercise Prices [Abstract]
Outstanding, beginning of period (in dollars per share)					$ 12.55
Granted (in dollars per share)					10.04
Cancelled (in dollars per share)					10.04
Outstanding, end of period (in dollars per share)		$ 10.04			10.04		$ 12.55
Exercisable (in dollars per share)		12.55			12.55
Maximum [Member]
Range of Exercise Prices [Abstract]
Outstanding, beginning of period (in dollars per share)					19.75
Granted (in dollars per share)					11.11
Cancelled (in dollars per share)					16.50
Outstanding, end of period (in dollars per share)		19.75			19.75		$ 19.75
Exercisable (in dollars per share)		$ 19.75			$ 19.75
2005 Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares available for issuance (in shares) | shares		0			0
Vested options (in shares) | shares		324,589			324,589
Unvested options (in shares) | shares		103,411			103,411
2015 Equity Incentive Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares available for issuance (in shares) | shares		119,000			119,000
Minimum number of plan administrators | Administrator		2			2
Unvested options (in shares) | shares		81,000			81,000
Maximum number of shares of Common Stock that can be delivered under the plan (in shares) | shares		200,000			200,000
[1]	The Company did not issue any options during the quarter ended September 30, 2016.
[2]	The expected life, in years, of stock options is estimated based on historical experience.
[3]	The risk-free interest rate is based on U.S. Treasury bills whose term is consistent with the expected life of the stock options.
[4]	The expected volatility is estimated based on historical and current stock price data for the Company.
[5]	Forfeitures are estimated based on historical experience.

DIVIDENDS (Details)

DIVIDENDS (Details)	Mar. 29, 2016	Dec. 31, 2015$ / shares	Sep. 30, 2015$ / shares	Jun. 30, 2015$ / shares	Mar. 31, 2015$ / shares	Dec. 31, 2014$ / shares	Sep. 30, 2014$ / shares	Jun. 30, 2014$ / shares	Mar. 31, 2014$ / shares	Dec. 31, 2013$ / shares
Dividends Payable [Line Items]
Quarterly Dividend Paid per Share (in dollars per share)		$ 0.22	$ 0.22	$ 0.22	$ 0.22	$ 0.22	$ 0.22	$ 0.22	$ 0.22	$ 0.22
Date Dividend Paid		Jan. 31, 2016	Oct. 31, 2015	Jul. 31, 2015	Apr. 30, 2015	Jan. 31, 2015	Oct. 31, 2014	Jul. 31, 2014	Apr. 30, 2014	Jan. 31, 2014
Minimum [Member]
Dividends Payable [Line Items]
Pro forma fixed charge coverage ratio	1.20

LINE OF CREDIT (Details)

LINE OF CREDIT (Details) - USD ($)	Mar. 30, 2016	Mar. 29, 2016	Sep. 30, 2016	Sep. 30, 2015
Long-term Debt [Line Items]
Repayments of lines of credit			$ 16,261,772	$ 20,856,031
Line of Credit [Member]
Long-term Debt [Line Items]
Debt instrument net worth minimum			$ 1,000,000
Percentage of net worth increased from net income			25.00%
Repayments of lines of credit	$ 10,600,000
Line of Credit [Member] | Maximum [Member]
Long-term Debt [Line Items]
Debt To EBITDA ratio for the twelve months ending December 31, 2016			3.15
Debt To EBITDA ratio for the twelve months ending March 31, 2017			3
Debt To EBITDA ratio for the twelve months ending June 30, 2017			2.10
Debt To EBITDA ratio for the twelve months ending September 30, 2017			2
Debt To EBITDA ratio after September 30, 2017			1.90
Debt To EBITDA ratio for the twelve months ending September 30, 2016			2.40
Line of Credit [Member] | Minimum [Member]
Long-term Debt [Line Items]
Fixed charge coverage ratio, Period one			1.35
Amount of generated EBITDA required to comply with covenant for the quarter ended December 31, 2016			$ 650,000
Amount of generated EBITDA required to comply with covenant for the six months ending March 31, 2017			1,830,000
Domestic Line Of Credit Due March 2018 [Member]
Long-term Debt [Line Items]
Maximum borrowing capacity		$ 2,000,000
Amount outstanding			1,000,000
Amount available for borrowing			$ 1,000,000
Line of credit interest rate			3.42%
Maturity date			Mar. 31, 2018
Domestic Line Of Credit Due March 2021 [Member]
Long-term Debt [Line Items]
Amount outstanding		10,000,000	$ 9,000,000
Quarterly payment of loan payable		$ 500,000
Line of credit interest rate			3.42%
Maturity date			Mar. 31, 2021
LIBOR Borrowing Rate [Member] | Domestic Line Of Credit Due March 2018 [Member] | Maximum [Member]
Long-term Debt [Line Items]
Basis spread on variable rate		2.90%
LIBOR Borrowing Rate [Member] | Domestic Line Of Credit Due March 2018 [Member] | Minimum [Member]
Long-term Debt [Line Items]
Basis spread on variable rate		2.25%
LIBOR Borrowing Rate [Member] | Domestic Line Of Credit Due March 2021 [Member] | Maximum [Member]
Long-term Debt [Line Items]
Basis spread on variable rate		2.90%
LIBOR Borrowing Rate [Member] | Domestic Line Of Credit Due March 2021 [Member] | Minimum [Member]
Long-term Debt [Line Items]
Basis spread on variable rate		2.25%

DISCLOSURES ABOUT FAIR VALUE 25

DISCLOSURES ABOUT FAIR VALUE OF FINANCIAL INSTRUMENTS (Details) - USD ($)	9 Months Ended
	Sep. 30, 2016	Dec. 31, 2015
Contingent Liabilities [Abstract]
Number of years until the contingent liability becomes payable	4 years
Number of trailing months of operating cash flow used to determine contingent liability	12 months
Fair Value, Measurements, Recurring [Member] | Fair Value, Inputs, Level 1 [Member]
Liabilities, Fair Value Disclosure [Abstract]
Contingent Liabilities Balance	$ 0	$ 0
Fair Value, Measurements, Recurring [Member] | Fair Value, Inputs, Level 2 [Member]
Liabilities, Fair Value Disclosure [Abstract]
Contingent Liabilities Balance	0	0
Fair Value, Measurements, Recurring [Member] | Fair Value, Inputs, Level 3 [Member]
Liabilities, Fair Value Disclosure [Abstract]
Contingent Liabilities Balance	$ 321,000	$ 321,000